Coumarin derivatives as protease inhibitors and antiviral agents
AssigneeWarner-Lambert Company
InventorsJohn M. Domagala, Susan E. Hagen, Elizabeth Lunney, Bradley D. Tait
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel coumarin derivatives and related compounds which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The coumarin derivatives are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of multifunctionalized coumarins and of related structures.
Claims8
A compound or a pharmaceutically acceptable salt thereof of formula ##STR12## wherein X is OR.sub.1 or SH wherein R.sub.1 is hydrogen or COR.sub.2 wherein R.sub.2 is a straight or branched alkyl chain containing 1 to 5 carbon atoms, a cyclic alkyl containing 3 to 6 carbon atoms, or a hydrogen atom;
- Z is oxygen or sulfur;
- Y is oxygen;
- W is oxygen, NR.sub.3, C(R.sub.3).sub.2, NCOV.sub.n4 R.sub.3, NR.sub.3 COV.sub.n4, CO, CH.dbd.CH, S(O).sub.n3, C.tbd.C, CNOR4, or CR.sub.3 OR.sub.3 wherein V is oxygen, sulfur, NR.sub.3, or CHR.sub.3 ;
- R.sub.3 is (CH.sub.2).sub.n3 Ar wherein Ar is phenyl, naphthyl, or a substituted derivative thereof wherein the substituents are one or more of F, Cl, Br, OR.sub.4, N(R.sub.4).sub.2, NO.sub.2, CO.sub.2 R.sub.4, CON(R.sub.4).sub.2, COR.sub.4, R.sub.4, OCH.sub.2 O, OCH.sub.2 CH.sub.2 O, or CN;
- R.sub.4 is hydrogen, a straight or branched alkyl group consisting of 1 to 5 carbon atoms, a cycloalkyl consisting of 3 to 6 carbon atoms, or a substituted derivative thereof wherein the substituents are one or more of CO.sub.2 R.sub.2, CON(R.sub.2).sub.2, F, OR.sub.2, phenyl, naphthyl, or CF.sub.3 ;
- n1, n2, n3, and n4 are integers of from 0 to 4, 0 to 4, 0 to 2, and 0 to 1, respectively, with the proviso that n2 is zero when intra-chain n4 is zero, and with the further proviso that n2 is of from two to four when two intra-chain groups W are heteroatoms;
- and
- A and B are independently F, Cl, Br, OR.sub.4, N(R.sub.4).sub.2, NO.sub.2, CO.sub.2 R.sub.4, CON(R.sub.4).sub.2, COR.sub.4, R.sub.4, OCH.sub.2 O, OCH.sub.2 CH.sub.2 O, or CN.
A compound selected from the group consisting of
- 4-Hydroxy-3- 3- 3-(hydroxymethylphenoxy!propyl!-2H-1-benzopyran-2-one,
- 4-Hydroxy-3- 2-(phenylmethoxy)ethyl!-2H-1-benzopyran-2-one,
- 3- 3-(3-Aminophenoxy)propyl!-4-hydroxy-2H-1-benzopyran-2-one,
- 4-Hydroxy-3- 4-(2-methoxyphenyl)butyl!-2H-1-benzopyran-2-one,
- 4-Hydroxy-3- 4-(2-hydroxyphenyl)butyl!-2H-1-benzopyran-2-one,
- 4-Hydroxy-3- 3-(4-methoxyphenoxy)propyl!-2H-1-benzopyran-2-one,
- 3- 3-(3-Chlorophenoxy)propyl!-4-hydroxy-2H-1-benzopyran-2-one,
- 4-Hydroxy-7-methoxy-3- 4-(2-methoxyphenyl)butyl!-2H-1-benzopyran-2-one,
- 4-Hydroxy-3- 3-methyl-1-(2-phenoxyethyl)butyl!2H-1-benzopyran-2-one,
- 4-Hydroxy-3-(3-phenoxy-4-phenylbutyl)-2H-1-benzopyran-2-one,
- 4-Hydroxy-3- 2-phenyl-1- (phenylmethyl)thio!ethyl!-2H-1-benzopyran-2-one,
- 4-Hydroxy- 3-phenoxy-1-(phenylmethyl)propyl!-2H-1-benzopyran-2-one,
- Ethyl 3- 3-(4-hydroxy-2-oxo-2H-1-benzypyran-3-yl)propoxy!benzoate,
- 3- 3-(3-Cyanophenoxy)propyl!-4-hydroxy-2H-1-benzopyran-2-one,
- 4,7-Dihydroxy-3- 4-(2-methoxyphenyl)butyl!-2H-1-benzopyran-2-one, and
- 3- (Cyclohexylthio)phenylmethyl!-4-hydroxy-2H-1-benzopyran-2-one.
Dependencies are inferred from the claim text.